Small Molecules Anti-HIV Therapeutics Targeting CXCR4

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|4|385-404

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.4, 2008-02, pp. : 385-404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small-Molecule Antagonists of CCR5 and CXCR4: A Promising New Class of Anti-HIV-1 Drugs

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2041-2062

Bentham Science Publishers

Access to resources Recommend Favorite

A Combined Cheminformatics and Computational Approach for the Prediction of Anti-HIV Small Molecules

By  

Current Computer - Aided Drug Design, Vol. 10, Iss. 4, 2014-12 ,pp. : 349-353

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting CXCR4 in HIV Cell-Entry Inhibition.

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 14, 2009-12 ,pp. : 1605-1621

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-HIV microbicide development: targeting the virus is the key

By O’’Keefe Barry R  

Future Virology, Vol. 6, Iss. 5, 2011-05 ,pp. : 553-556

Future Medicine

Access to resources Recommend Favorite

Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor

By Vermeire Kurt   Schols Dominique  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 10, 2005-10 ,pp. : 1199-1212

Informa Healthcare

Access to resources Recommend Favorite